+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Elusys Therapeutic Inc - logo

Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. Elusys is engaged in the development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores. In particular, Elusys is currently focusing on late-stage clinical trials of Anthim (Obiltoxaximab) to be used for treatment and prevention of inhaled anthrax.

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026

  • Report
  • October 2021
  • 210 Pages
  • Global
From
From
From
Anthrax - Pipeline Review, H2 2020 - Product Thumbnail Image

Anthrax - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 126 Pages
  • Global
From
From
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator